Issued Patents All Time
Showing 26–50 of 156 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9932413 | Murine, chimeric, humanized or human anti-IL-6 antibodies | David M. Goldenberg, Rongxiu Li | 2018-04-03 |
| 9931413 | Tetrameric cytokines with improved biological activity | David M. Goldenberg, Edmund A. Rossi | 2018-04-03 |
| 9920116 | Methods for treating ischemic stroke using chimeric and humanized anti-histone antibodies | Hans J. Hansen, David M. Goldenberg | 2018-03-20 |
| 9879088 | Disease therapy by inducing immune response to Trop-2 expressing cells | David M. Goldenberg, Edmund A. Rossi, Diane Rossi | 2018-01-30 |
| 9872920 | PEGylation by the dock and lock (DNL) technique | David M. Goldenberg, William J. McBride, Edmund A. Rossi | 2018-01-23 |
| 9862770 | Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors | David M. Goldenberg | 2018-01-09 |
| 9839689 | Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy | David M. Goldenberg | 2017-12-12 |
| 9809646 | Methods for treating thrombosis using chimeric and humanized anti-histone antibodies | Hans J. Hansen, David M. Goldenberg | 2017-11-07 |
| 9797907 | Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells | David M. Goldenberg, Hans J. Hansen | 2017-10-24 |
| 9757458 | Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells | David M. Goldenberg | 2017-09-12 |
| 9751948 | Class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type I receptor (IGF-1R) | Michele J. Losman, David M. Goldenberg | 2017-09-05 |
| 9745374 | Fusion proteins containing recombinant cytotoxic RNAses | David M. Goldenberg, Hans J. Hansen, Sailaja S. Vanama, Edmund A. Rossi | 2017-08-29 |
| 9737617 | Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases | David M. Goldenberg, Edmund A. Rossi | 2017-08-22 |
| 9707300 | Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites | Serengulam V. Govindan, Sung-Ju Moon, David M. Goldenberg | 2017-07-18 |
| 9701748 | Humanized anti-CD22 antibody | David M. Goldenberg | 2017-07-11 |
| 9687547 | T20 constructs for anti-HIV (human immunodeficiency virus) therapy and/or vaccines | Sofia Stenler, Britta Wahren, David M. Goldenberg | 2017-06-27 |
| 9682143 | Combination therapy for inducing immune response to disease | David M. Goldenberg, Edmund A. Rossi, Diane Rossi | 2017-06-20 |
| 9670286 | Disease therapy by inducing immune response to Trop-2 expressing cells | David M. Goldenberg, Edmund A. Rossi, Diane Rossi | 2017-06-06 |
| 9663576 | Therapeutic use of anti-CD22 antibodies for inducing trogocytosis | David M. Goldenberg, Hans J. Hansen, Edmund A. Rossi | 2017-05-30 |
| 9657093 | Methods for treating sepsis using chimeric and humanized anti-histone antibodies | Hans J. Hansen, David M. Goldenberg | 2017-05-23 |
| 9623115 | Dock-and-Lock (DNL) Complexes for Disease Therapy | David M. Goldenberg | 2017-04-18 |
| 9617531 | Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock | David M. Goldenberg, Edmund A. Rossi | 2017-04-11 |
| 9599619 | Anti-pancreatic cancer antibodies | David M. Goldenberg, Hans J. Hansen, David V. Gold | 2017-03-21 |
| 9555661 | Electric pencil sharpener with a replaceable cutter assembly | Che-Chang Cheng, Liang-Liang Yao | 2017-01-31 |
| 9550838 | Dock-and-lock (DNL) complexes for therapeutic and diagnostic use | David M. Goldenberg | 2017-01-24 |